Share

Networks

Clinical Studies (5)

  • SPIRAV : Study aims to assess pregnant women’s adherence to current infant RSV prevention strategies in France, focusing on the option most commonly chosen (either maternal vaccination with Abrysvo® during pregnancy or neonatal administration of Beyfortus®) and to identify factors influencing the choice between strategies, as well as the main reasons women report for adopting or not adopting each strategy
  • CARBO : Study aims to identify demographic, clinical, biological, virologic, immunologic and genetic factors associated with or predictive of severe complications of arbovirus infections in a cohort of children and adults with confirmed arbovirus infections
  • Aguilaniu : Study aims to conduct a large descriptive analysis of cardiopulmonary exercise testing to improve the understanding of persistent symptoms and in particular the diversity of physiological response presentations in post acut SARS-CoV-2 infection patients
  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.
  • COVENTRY : Study aims to evaluate the long-term outcomes of COVID-19 patients who survived an intensive care unit stay and were admitted in a post-ICU setting, focusing on quality of life, dependence, and survival one year after discharge

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Fragile population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Immunocompromised host
  • Pregnant women
  • Hospital
  • Outpatient clinic
  • Emergency department
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • Zika virus
  • West Nile virus
  • Japanese encephalitis virus
  • Post COVID-19 condition
  • Acute COVID-19
  • Respiratory syncytial virus infection
  • Arboviral disease
  • Vector-borne disease
  • Pharmacological intervention
  • Monoclonal antibodies
  • Vaccination
  • Sotrovimab
  • Nirsevimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • Abrysvo

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to